Post Archive by Month

For the first time, scientists have detected the monkeypox virus (MPXV) in the testes of macaques, according to research published in the journal Nature Microbiology.
In addition, these researchers found preliminary evidence of persistent infection in two animals that survived challenges with the virus.
This data provide evidence that MPXV may be shed into semen during both acute and convalescent stages of the disease.
Their results, published on October 17, 2022, highlight the potential for sexual transmission of the MPXV in humans.

Novavax, Inc. announced that the protein-based Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373), had received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) to provide a first booster dose of at least six months after completion of primary vaccination with an authorized or approved COVID-19 vaccine to individuals 18 years of age and older for whom an FDA-authorized mRNA bivalent COVID-19 booster vaccine is not accessible or clinically appropriate.

Since the monkeypox virus (MPXV) outbreak began in May 2022, occupationally acquired infections in healthcare personnel (HCP) have rarely been reported.
However, since the U.S. government expanded the list of HCP authorized to administer MPXV vaccines to include nurses and pharmacists on October 3, 2022, the risk of work-related exposure has increased.
The recent U.S. CDC's Morbidity and Mortality Weekly Report describes how a nurse's exposure to MPXV through a needlestick can lead to a positive case.

Since the monkeypox virus (MPXV) outbreak began in May 2022, occupationally acquired infections in healthcare personnel (HCP) have rarely been reported.
However, since the U.S. government expanded the list of HCP authorized to administer MPXV vaccines to include nurses and pharmacists on October 3, 2022, the risk of work-related exposure has increased.
The recent U.S. CDC's Morbidity and Mortality Weekly Report describes how a nurse's exposure to MPXV through a needlestick can lead to a positive case.

The current rapid spread of the monkeypox virus and other pathogens shows just how important it is to invest early in disease research so that we can be better prepared for future infectious disease threats, whenever or wherever they may strike, wrote GAVI.
On October 10, 2022, Jodie Rogers wrote one such disease with epidemic potential is Rift Valley fever, which was initially identified in the 1930s,
Spread by a virus of the same name, this potentially deadly Rift Valley fever causes periodic outbreaks across Africa and parts of the Arabian Peninsula.

Recent announcements indicate innovative technologies may provide new clinical solutions for the 36.9 million people living with HIV/AIDS worldwide. 
The current standard of care for these people of all ages is a combination of antiretroviral therapies, which may control the disease, but are not curative, as they cannot target integrated HIV-1 genomes, says HIV.gov.
Recently, a potential cure for human immunodeficiency virus type 1 (HIV-1) created with CRISPR-based editing of HIV proviral DNA was announced.